![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 21
Zeitschriftenartikel
Pretzsch, E.; Niess, H.; Boesch, F.; Westphalen, C. B.; Jacob, S.; Neumann, J.; Werner, J.; Heinemann, V. und Angele, M. K.
(2022):
Age and metastasis - How age influences metastatic spread in cancer. Colorectal cancer as a model.
In: Cancer Epidemiology, Bd. 77, 102112
Pretzsch, E.; Max, N.; Kirchner, T.; Engel, J.; Werner, J.; Klauschen, F.; Angele, M. K. und Neumann, J.
(2021):
LIN28 promotes tumorigenesis in colorectal cancer but is not associated with metastatic spread.
In: Pathology Research and Practice, Bd. 228, 153669
Rosado-Belza, D.; Falcon-Barroso, J.; Knapen, J. H.; Bittner, A.; Gadotti, D. A.; Neumann, J.; de Lorenzo-Caceres, A.; Mendez-Abreu, J.; Querejeta, M.; Martin-Navarro, I.; Sanchez-Blazquez, P.; Coelho, P. R. T.; Martig, M.; Ven, G. van de und Kim, T.
(2020):
The kinematics of young and old stellar populations in nuclear rings of MUSE TIMER galaxies.
In: Astronomy & Astrophysics, Bd. 644, A116
Bittner, A.; Falcon-Barroso, J.; Nedelchev, B.; Dorta, A.; Gadotti, D. A.; Sarzi, M.; Molaeinezhad, A.; Iodice, E.; Rosado-Belza, D.; de Lorenzo-Caceres, A.; Fragkoudi, F.; Galan-de Anta, P. M.; Husemann, B.; Mendez-Abreu, J.; Neumann, J.; Pinna, F.; Querejeta, M.; Sanchez-Blazquez, P. und Seidel, M. K.
(2019):
The GIST pipeline: A multi-purpose tool for the analysis and visualisation of (integral-field) spectroscopic data.
In: Astronomy & Astrophysics, Bd. 628, A117
Pretzsch, E.; Boesch, F.; Neumann, J.; Ganschow, P.; Bazhin, A.; Guba, M.; Werner, J. und Angele, M.
(2019):
Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread.
In: Journal of Oncology, Bd. 2019, 7407190
[PDF, 1MB]
Hao, J.; Miksch, R.; Anger, H.; Zhu, T.; Bucher, J.; D'Haese, J.; Mayer, B.; Neumann, J.; Guba, M.; Werner, J.; Bazhin, A. und Schönberg, M.
(2017):
Perivascular Infiltration Of Lymphocytes Influence Of The Disease-Free Survival After Resection Of Hepatocellular Carcinoma.
In: Transplant international, Bd. 30: S. 39
D’Haese, Jan Goesta; Neumann, J.; Weniger, Maximilian; Pratschke, S.; Bjornsson, B.; Ardiles, V.; Chapman, W.; Hernandez-Alejandro, R.; Soubrane, O.; Robles-Campos, R.; Stojanovic, M.; Dalla Valle, R.; Chan, A. C.; Coenen, Michaela; Guba, M.; Werner, Jens; Schadde, E. und Angele, Martin Kurt
(2016):
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
In: Annals of Surgical Oncology, Bd. 23, Nr. 4: S. 1335-1343
Stahler, A.; Heinemann, V.; Clemens, G.; Crispin, A.; Schalhorn, A.; Stintzing, S.; Fischer von Weikersthal, L.; Vehling-Kaiser, U.; Stauch, M.; Quietzsch, D.; Held, S.; Einem, J. C. von; Holch, J.; Neumann, J.; Kirchner, T.; Jung, A. und Modest, D. P.
(2016):
Prevalence and influence on outcome of Neuregulin- (NRG1), HER2/neu- and HER3-expression in patients with metastatic colorectal cancer (mCRC) treated with irinotecan-based first-line regimens (FUFIRI vs. mIROX) in the FIRE 1-trial.
In: Oncology Research and Treatment, Bd. 39: S. 72
Kaemmerer, D.; Saenger, J.; Arsenic, R.; D'Haese, J.; Neumann, J.; Schulz, S. und Lupp, A.
(2016):
Evaluation of the Somatostatin, CXCR4 Chemokine and Endothelin A Receptor Expression in a Large Series of Paragangliomas.
In: Neuroendocrinology, Bd. 103: S. 47
Michl, M.; Heinemann, V.; Jung, A.; Engel, Jutta; Kirchner, T. und Neumann, J.
(2015):
Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system.
In: Pathology, Research and Practice, Bd. 211, Nr. 8: S. 601-609
Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta und Heinemann, V.
(2015):
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
In: Clinical Colorectal Cancer, Bd. 14, Nr. 4: S. 281-290
Stahler, A.; Heinemann, V.; Giessen-Jung, C.; Crispin, Alexander; Schalhorn, A.; Stintzing, S.; Fischer von Weikersthal, L.; Vehling-Kaiser, U.; Stauch, M.; Quietzsch, D.; Held, S.; Einem, J. C. von; Holch, J.; Neumann, J.; Kirchner, T.; Jung, A. und Modest, D. P.
(2015):
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
In: International Journal of Cancer, Bd. 138, Nr. 3: S. 739-746
Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Ormanns, S.; Haas, M.; Modest, D. P.; Kirchner, T. und Heinemann, V.
(2013):
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer.
In: Journal of Gastroenterology, Bd. 48, Nr. 4: S. 544-548
Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Vehling-Kaiser, U.; Winkelmann, C.; Fischer von Weikersthal, L.; Clemens, M. R.; Gauler, T. C.; Marten, A.; Klein, S.; Kojouharoff, G.; Barner, M.; Geissler, M.; Greten, T. F.; Mansmann, Ulrich; Kirchner, T. und Heinemann, V.
(2013):
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.
In: British Journal of Cancer BJC, Bd. 108, Nr. 2: S. 469-476
Siemens, H.; Neumann, J.; Jackstadt, R.; Mansmann, Ulrich; Horst, D.; Kirchner, T. und Hermeking, H.
(2013):
Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer.
In: Clinical Cancer Research, Bd. 19, Nr. 3: S. 710-720
Neumann, J.; Wehweck, L.; Maatz, S.; Engel, Jutta; Kirchner, T. und Jung, A.
(2013):
Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
In: Virchows Archiv, Bd. 463, Nr. 4: S. 509-523
Modest, D. P.; Jung, A.; Moosmann, N.; Laubender, Rüdiger P.; Giessen, C.; Schulz, C.; Haas, M.; Neumann, J.; Boeck, S.; Kirchner, T.; Heinemann, V. und Stintzing, S.
(2012):
The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial.
In: International Journal of Cancer, Bd. 131, Nr. 4: S. 980-986
Neumann, J.; Horst, D.; Kriegl, L.; Maatz, S.; Engel, Jutta; Jung, A. und Kirchner, T.
(2012):
A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.
In: Histopathology, Bd. 60, Nr. 3: S. 416-426
Herbst, A.; Rahmig, K.; Stieber, P.; Philipp, A.; Jung, A.; Ofner, A.; Crispin, Alexander; Neumann, J.; Lamerz, R. und Kolligs, F. T.
(2011):
Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
In: American Journal of Gastroenterology, Bd. 106, Nr. 6: S. 1110-1118
Modest, D. P.; Stintzing, S.; Laubender, Rüdiger P.; Neumann, J.; Jung, A.; Giessen, C.; Haas, M.; Aubele, P.; Schulz, C.; Boeck, S.; Stemmler, H. J.; Kirchner, T. und Heinemann, V.
(2011):
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
In: Anticancer Drugs, Bd. 22, Nr. 9: S. 913-918
Habermann, J.; Heinze, H. G.; Horn, K.; Kantlehner, R.; Marschner, I.; Neumann, J. und Scriba, Peter Christian
(1975):
Alimentärer Jodmangel in der Bundesrepublik Deutschland.
In: Deutsche medizinische Wochenschrift, Bd. 100: S. 1937-1945
[PDF, 3MB]